IBS is multifactorial in its etiology and heterogeneous in its clinical presentation and pathogenesis. Previous gastroenteritis has been identified as the most important risk factor for IBS. Recent studies have recognized that inflammation plays an important role in symptom generation, at least in a subset of patients with IBS. Characterized by powerful and real pharmacological activities, IBS DropsRx unequivocally qualifies as an ethical drug for IBS treatment.
Irritable
bowel syndrome (IBS), the most common disorder seen in patients with
gastrointestinal complaints, consists of altered bowel habits, such
as diarrhea, constipation or alternation of the two, along with
abdominal pain and intolerance to flatus, without any detectable
organic disease. It should not be confused with colitis or other
inflammatory diseases of the intestinal tract.
IBS
is a functional gastrointestinal disorder in which abdominal pain is
associated with a defect or a change in bowel habits. Gut
inflammation is one of the proposed mechanisms of pathogenesis.
Recent studies have described a possible role for protozoan
parasites, such as Blastocystis hominis and Dientamoeba fragilis, in
the etiology of IBS.
Dientamoeba
fragilis is known to cause IBS-like symptoms and has a propensity to
cause chronic infections but its diagnosis relies on microscopy of
stained smears, which many laboratories do not perform, thereby
leading to the misdiagnosis of dientamoebiasis as IBS. The role of B.
hominis as an etiological agent of IBS is inconclusive, due to
contradictory reports and the controversial nature of B. hominis as a
human pathogen.
Although
Entamoeba histolytica infections occur predominately in developing
regions of the world, clinical diagnosis of amebiasis is often
difficult because symptoms of patients with IBS may closely mimic
those patients with non-dysenteric amoebic colitis. Clinical
manifestations of Giardia intestinalis infection also vary from
asymptomatic carriage to acute and chronic diarrhoea with abdominal
pain.
These
IBS-like symptoms can be continuous, intermittent, sporadic or
recurrent, sometimes lasting years without correct diagnosis. It is
essential that all patients with IBS undergo routine parasitological
investigations in order to rule out the presence of protozoan
parasites as the causative agents of the clinical signs.
IBS
is multifactorial in its etiology and heterogeneous in its clinical
presentation and pathogenesis. Previous gastroenteritis has been
identified as the most important risk factor for IBS, and several
studies reported that a substantial proportion of patients with
gastrointestinal infection develops IBS symptoms, which can persist
for several years.
Recent
studies have demonstrated that a proportion of IBS patients without
any history of enteritis has signs of immune activation in the gut.
There is clinical overlap between IBS and inflammatory bowel disease
(IBD), with IBS-like symptoms frequently reported in patients before
the diagnosis of IBD, and a higher than expected percentage reports
of IBS symptoms in patients in remission from established IBD.
Irritable
bowel syndrome often disrupts daily living activities. Nineteen
percent of respondents in a survey of married or cohabiting people
with IBS stated they had difficulties in their personal
relationships, and 45% stated that itinterfered with their sex life.
The need for effective irritable bowel syndrome treatment is
therefore of a high priority.
Very
recent advances in the scientific understanding of the medicinal
plant extracts in IBS
DropsRx
suggest a much broader use of natural medicine to provide effective
treatment for IBS and other related disorders than science thought
possible just ten years ago. The therapeutic effectiveness of the
active compounds in the IBS treatment is unparalleled and
substantiated on a global scale.
IBS
DropsRx is concentrated with a wide spectrum of medicinal plant
extracts exhibiting effective irritable bowel syndrome treatment, as
demonstrated by a wealth of scientific and clinical studies.
Characterized by powerful and real pharmacological activities, IBS
DropsRx unequivocally qualifies as an ethical drug for IBS treatment.
Today,
doctors and scientists have confirmed the substantial IBS treatment
value of IBS DropsRx extracts as being stomachic, carminative, and
antispasmodic. They have a positive effect on nervous disorders,
flatulence and colitis and used for the treatment of IBS. There are
few, if any, remedies of greater efficacy in treatment for IBS.
In
order to provide full reversal of the condition and produce the
absolute best IBS treatment, IBS DropsRx have been concentrated with
a wide spectrum of very specific plant extracts exhibiting a curative
effect in treatment for IBS. To learn more, please go to
http://www.naturespharma.org.
| About the author |
staff of Nature Power Company, which is a network company dedicated to promoting customers' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net http://www.naturespharma.org |
| Additional articles about Irritable Bowel Syndrome |
|
|
| Please Rate This Article |
Number of ratings: 0
Rating: 0